The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Diradoorian Raymond H since 2006.
This trader's CIK number is 1352121.
At the time of last reporting, Diradoorian Raymond H was the Officer of Lifecore Biomedical, Inc. \de\. (stock ticker symbol LFCR).
Also see all insider trading activities at Lifecore Biomedical, Inc. \de\.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | AGN | 0 | $0 | 0 | $0 | 277 | $0 |
| 2014 | AGN | 0 | $0 | 40,000 | $4,984,068 | 40,000 | $2,298,225 |
| 2012 | AGN | 0 | $0 | 25,000 | $2,275,575 | 25,000 | $1,399,375 |
| 2011 | AGN | 0 | $0 | 51,205 | $4,127,409 | 53,000 | $1,881,149 |
| 2010 | AGN | 0 | $0 | 33,830 | $2,254,883 | 35,706 | $1,260,495 |
| 2009 | AGN | 0 | $0 | 20,136 | $1,184,701 | 20,136 | $526,193 |
| 2008 | AGN | 0 | $0 | 10,000 | $583,860 | 10,000 | $166,900 |
| 2007 | AGN | 0 | $0 | 34,312 | $2,315,972 | 34,312 | $1,480,326 |
| 2006 | AGN | 0 | $0 | 10,000 | $1,066,240 | 10,000 | $382,620 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | LFCR | 0 | $0 | 0 | $0 | 9,554 | $0 |
| 2023 | LFCR | 0 | $0 | 0 | $0 | 9,474 | $0 |
2. Lifecore Biomedical, Inc. \de\ (LFCR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-02-20 | AGN | Option Ex | 277 | .00 | 0 |
| 2014-02-19 | AGN | Option Ex | 23,000 | 58.55 | 1,346,650 |
| 2014-02-19 | AGN | Sale | 23,000 | 126.66 | 2,913,111 |
| 2014-02-11 | AGN | Sale | 17,000 | 121.82 | 2,070,957 |
| 2014-02-11 | AGN | Option Ex | 17,000 | 55.98 | 951,575 |
| 2012-11-20 | AGN | Option Ex | 25,000 | 55.98 | 1,399,375 |
| 2012-11-20 | AGN | Sale | 25,000 | 91.02 | 2,275,575 |
| 2011-10-28 | AGN | Option Ex | 33,200 | 38.70 | 1,284,674 |
| 2011-10-28 | AGN | Sale | 33,200 | 84.44 | 2,803,574 |
| 2011-02-15 | AGN | Sale | 18,005 | 73.53 | 1,323,835 |
| 2011-02-15 | AGN | Option Ex | 19,800 | 30.12 | 596,475 |
| 2010-11-15 | AGN | Option Ex | 22,212 | 32.39 | 719,535 |
| 2010-11-15 | AGN | Sale | 20,336 | 69.42 | 1,411,765 |
| 2010-05-11 | AGN | Option Ex | 13,494 | 40.09 | 540,960 |
| 2010-05-11 | AGN | Sale | 13,494 | 62.48 | 843,118 |
| 2009-11-05 | AGN | Option Ex | 20,136 | 26.13 | 526,193 |
| 2009-11-05 | AGN | Sale | 20,136 | 58.84 | 1,184,701 |
| 2008-07-29 | (AGN) | Option Ex | 5,000 | 16.69 | 83,450 |
| 2008-07-29 | (AGN) | Sale | 5,000 | 52.05 | 260,250 |
| 2008-02-12 | (AGN) | Option Ex | 5,000 | 16.69 | 83,450 |
| 2008-02-12 | (AGN) | Sale | 5,000 | 64.72 | 323,610 |
| 2007-11-16 | AGN | Option Ex | 4,000 | 16.69 | 66,760 |
| 2007-11-16 | AGN | Sale | 4,000 | 64.41 | 257,648 |
| 2007-06-29 | AGN | Sale | 10,532 | 58.14 | 612,362 |
| 2007-06-29 | AGN | Option Ex | 10,532 | 44.27 | 466,251 |
| 2007-06-29 | AGN | Sale | 14,532 | 58.13 | 844,774 |
| 2007-06-29 | AGN | Option Ex | 14,532 | 53.13 | 772,085 |
| 2007-02-14 | AGN | Option Ex | 2,000 | 33.39 | 66,780 |
| 2007-02-14 | AGN | Sale | 2,000 | 112.86 | 225,720 |
| 2007-02-07 | AGN | Sale | 3,248 | 115.60 | 375,468 |
| 2007-02-07 | AGN | Option Ex | 3,248 | 33.39 | 108,450 |
| 2006-04-06 | AGN | Option Ex | 4,000 | 16.71 | 66,840 |
| 2006-04-06 | AGN | Sale | 4,000 | 104.38 | 417,520 |
| 2006-04-05 | AGN | Option Ex | 6,000 | 52.63 | 315,780 |
| 2006-04-05 | AGN | Sale | 6,000 | 108.12 | 648,720 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-01 | LFCR | Option Ex | 9,554 | .00 | 0 |
| 2023-05-31 | LFCR | Option Ex | 9,474 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Diradoorian Raymond H (Officer of Lifecore Biomedical, Inc. \de\ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.